-
公开(公告)号:US20100292322A1
公开(公告)日:2010-11-18
申请号:US12086547
申请日:2006-12-21
申请人: Alberto Bernareggi , Mario Grugni , Giulio Mariotti , Ernesto Menta , Gianluca Pardi , Paolo Pavesi , Gabriella Pezzoni , Paolo Nicoli , Sergio De Munari
发明人: Alberto Bernareggi , Mario Grugni , Giulio Mariotti , Ernesto Menta , Gianluca Pardi , Paolo Pavesi , Gabriella Pezzoni , Paolo Nicoli , Sergio De Munari
CPC分类号: C07F15/0093
摘要: A compound of general formula (I): in which: R is selected from the group consisting of (C1-C25)alkyl, (C2-C25)alkenyl, aryl, (C7-C10)aralkyl; n and m are each independently an integer of two to eight; p is one or two; A is selected from the group consisting of —B—, —B—(CH2)r—B—, —B—(CH2)r—B—(CH2)z—B—, wherein r and z are an integer from 2 to 8, B is a —NR1— or —N(R2)2+ 1/pQ−p group, in which R1 is selected from hydrogen, (C1-C4)alkyl, (C1-C4)acyl, tert-butoxycarbonyl, and R2 is selected from hydrogen and (C1-C4)alkyl; Q−p is an anion selected from chloride, bromide, iodide, nitrate, sulphate, hydrogen sulphate, perchlorate, R3COO− wherein R3 has the same meanings as R, independently from one another and R4—O—SO3− wherein R4 is (C2-C14)alkyl with the proviso that, when Q−p is selected from chloride, bromide, iodide, nitrate, sulphate, hydrogen sulphate, perchlorate, R is not (C1-C4)alkyl.
摘要翻译: 通式(I)的化合物:其中:R选自(C 1 -C 25)烷基,(C 2 -C 25)烯基,芳基,(C 7 -C 10)芳烷基; n和m各自独立地为2至8的整数; p是一两个; A选自-B-,-B-(CH2)r-B-,-B-(CH2)r-B-(CH2)z-B-,其中r和z是2的整数 至(C 1 -C 4)烷基,(C 1 -C 4)酰基,叔丁氧基羰基,C 1 -C 4烷基, 并且R 2选自氢和(C 1 -C 4)烷基; Q-p是选自氯化物,溴化物,碘化物,硝酸盐,硫酸盐,硫酸氢盐,高氯酸盐,R3COO-中的一种阴离子,其中R3具有与R相同的含义,R4-O-SO3-,其中R4是(C2 -C 14)烷基,条件是当Q-p选自氯化物,溴化物,碘化物,硝酸盐,硫酸盐,硫酸氢盐,高氯酸盐时,R不是(C 1 -C 4)烷基。
-
公开(公告)号:US08426625B2
公开(公告)日:2013-04-23
申请号:US12086547
申请日:2006-12-21
申请人: Alberto Bernareggi , Mario Grugni , Giulio Mariotti , Ernesto Menta , Gianluca Pardi , Paolo Pavesi , Gabriella Pezzoni , Paolo Nicoli , Sergio De Munari
发明人: Alberto Bernareggi , Mario Grugni , Giulio Mariotti , Ernesto Menta , Gianluca Pardi , Paolo Pavesi , Gabriella Pezzoni , Paolo Nicoli , Sergio De Munari
CPC分类号: C07F15/0093
摘要: A compound of general formula (I): in which: R is selected from the group consisting of (C1-C25)alkyl, (C2-C25)alkenyl, aryl, (C7-C10)aralkyl; n and m are each independently an integer of two to eight; p is one or two; A is selected from the group consisting of —B—, —B—(CH2)r—B—, —B—(CH2)r—B—(CH2)z—B—, wherein r and z are an integer from 2 to 8, B is a —NR1— or —N(R2)2+1/pQ−p group, in which R1 is selected from hydrogen, (C1-C4)alkyl, (C1-C4)acyl, tert-butoxycarbonyl, and R2 is selected from hydrogen and (C1-C4)alkyl; Q−p is an anion selected from chloride, bromide, iodide, nitrate, sulphate, hydrogen sulphate, perchlorate, R3COO− wherein R3 has the same meanings as R, independently from one another and R4—O—SO3− wherein R4 is (C2-C14)alkyl with the proviso that, when Q−p is selected from chloride, bromide, iodide, nitrate, sulphate, hydrogen sulphate, perchlorate, R is not (C1-C4)alkyl.
摘要翻译: 通式(I)的化合物:其中:R选自(C 1 -C 25)烷基,(C 2 -C 25)烯基,芳基,(C 7 -C 10)芳烷基; n和m各自独立地为2至8的整数; p是一两个; A选自-B-,-B-(CH2)rB-,-B-(CH2)rB-(CH2)zB-,其中r和z是2至8的整数,B是 -NR 1 - 或-N(R 2)2 + 1 / pQ-p基团,其中R 1选自氢,(C 1 -C 4)烷基,(C 1 -C 4)酰基,叔丁氧基羰基和R 2选自氢 和(C 1 -C 4)烷基; Qp是选自氯化物,溴化物,碘化物,硝酸盐,硫酸盐,硫酸氢盐,高氯酸盐,R 3 COO-中的一种阴离子,其中R 3具有与R相同的含义,R 4 -O-SO 3 - 其中R 4是(C 2 -C 14 )烷基,条件是当Qp选自氯化物,溴化物,碘化物,硝酸盐,硫酸盐,硫酸氢盐,高氯酸盐时,R不是(C 1 -C 4)烷基。
-
公开(公告)号:US20130018096A1
公开(公告)日:2013-01-17
申请号:US13119278
申请日:2009-09-16
申请人: Sergio De Munari , Stefano Di Giovine , Mario Grugni , Paola Nicoli , Alessandro Paganelli , Gianluca Pardi , Gabriella Pezzoni
发明人: Sergio De Munari , Stefano Di Giovine , Mario Grugni , Paola Nicoli , Alessandro Paganelli , Gianluca Pardi , Gabriella Pezzoni
IPC分类号: A61K31/282 , A61P35/00 , C07F15/00
CPC分类号: C07F15/0093
摘要: The present invention relates to the antitumor compound of formula (I) a process for its preparation and pharmaceutical compositions containing it.
摘要翻译: 本发明涉及式(I)的抗肿瘤化合物及其制备方法和含有它的药物组合物。
-
公开(公告)号:US5175182A
公开(公告)日:1992-12-29
申请号:US613490
申请日:1990-11-05
IPC分类号: A61K31/00 , A61K31/395 , A61K31/40 , A61K31/415 , A61K31/495 , A61K31/787 , A61P35/00 , C07D207/34 , C07D403/12 , C07D403/14
CPC分类号: C07D403/12 , C07D207/34
摘要: The invention relates to acryloyl substituted pyrrole derivatives of formula (I) ##STR1## wherein n is an integer of 1 to 5;each of R.sub.1 and R.sub.2, which may be the same or different, is hydrogen, halogen, --CN, --NO.sub.2, C.sub.1 -C.sub.4 alkyl, or a group ##STR2## R.sub.3 is hydrogen, halogen, --CN, or --NO.sub.2 ; each R.sub.4 is, independently, hydrogen or C.sub.1 -C.sub.4 alkyl;A is a bond, a group ##STR3## or a group --NH--Het--CO--, wherein Het is a saturated or unsaturated pentatomic or hexatomic heteromonocyclic ring; andB is a group ##STR4## in which m is 1, 2 or 3 and each R.sub.5 is, independently, a C.sub.1 -C.sub.4 alkyl group, and pharmaceutically acceptable salts thereof, which are useful as antineoplastic agents.
-
公开(公告)号:US4987126A
公开(公告)日:1991-01-22
申请号:US308449
申请日:1989-02-10
IPC分类号: A61K31/65 , A61P35/00 , C07D309/10 , C07D309/14 , C07H15/252
CPC分类号: C07H15/252 , C07D309/10 , C07D309/14
摘要: Anthracycline glycoside compounds of general formula I or II: ##STR1## wherein R.sub.1 is hydrogen or a hydroxy group and R.sub.2 is hydrogen or a methoxy group, and their pharmaceutically acceptable acid addition salts, are antitumor agents.
-
-
-
-